Research, insights, and real talk about ketamine therapy and mental health.
Why most insurance plans won't cover IV ketamine for depression or chronic pain, why MCK is self-pay, and how the superbill plus HSA/FSA pathway actually works.
Read more →Why anesthesia training is the right credential for the person running an IV ketamine infusion — and how CRNA-led, MD-led, DNP-led, and RN-led clinic models actually differ.
Read more →Line-by-line breakdown of the $475 per session price at Music City Ketamine — what's included, what's not, and how that maps to a full induction series.
Read more →Intensity isn't the enemy. Here's how we walk patients through hard sessions — and what changes next time.
Read more →A quiet first session isn't failure. Here's what it usually means — and what we change before session two.
Read more →You usually don't have to name the medication. Here's a framework for workplace disclosure — not legal advice, but a place to start.
Read more →Seven specific marketing red flags in the ketamine clinic industry — guarantees, no screening, vague monitoring, no integration plan — and the questions to ask instead.
Read more →Office-based vs. hospital-based ketamine — what the AANA standards require, which indications fit each setting, and why Music City Ketamine is an outpatient office practice.
Read more →What happens after the six-session induction series — typical maintenance cadence, taper logic, restart triggers, and how we decide together at Music City Ketamine.
Read more →Not a weight-loss tool. Not the SSRI weight-gain story either. Here's the honest middle.
Read more →The vagus nerve runs the parasympathetic side of your nervous system. Some emerging research links ketamine response to vagal tone — but the mechanism is far from settled.
Read more →The glymphatic system is real. Whether ketamine meaningfully boosts it isn't settled. Here's what's known, what's emerging, and what's marketing hype.
Read more →The default mode network is the brain's rumination engine. Here's what Scheidegger 2012 and the imaging work that followed actually show about how ketamine quiets it.
Read more →The session does the priming. The day after does the work. Here's how to use the neuroplastic window.
Read more →Some patients sleep deep. Others lie awake and wired. Here's what the research says about the night after — and how to ride out either one.
Read more →The question patients quietly want answered. Here's what the research shows — and what to bring up with your prescriber.
Read more →Ketamine doesn't really cause neurogenesis. What it does — rapid synaptogenesis in the prefrontal cortex — is arguably more useful. Here's the honest version of the story.
Read more →Nausea is the side effect we plan around most. Here's how pre-meds, food timing, and a CRNA in the room keep most patients comfortable.
Read more →Day-of fog: normal. Long-term decline: not what the research shows at therapeutic doses. Here's the honest read.
Read more →Depression isn't a low-serotonin problem — it's increasingly understood as an excitatory/inhibitory balance problem. Here's what Sanacora and Krystal's groups have actually shown.
Read more →Same-day workouts: skip them. Next-day training: usually fine. Here's the recovery window in plain English.
Read more →Strange, vivid dreams after a session aren't a glitch — they're often part of how the work continues at night.
Read more →The 'entropic brain' hypothesis says rigid brain activity is part of what depression looks like. Here's where ketamine fits in Carhart-Harris's framework — and what's still hypothesis.
Read more →BDNF is the brain's grow-and-connect signal. Here's what Autry 2011 and the work that followed actually showed about how ketamine triggers it — and what that means for patients.
Read more →Ketamine blocks NMDA, but the antidepressant effect actually runs through AMPA. Here's the mechanism, in plain English, with the studies that nailed it down.
Read more →What happens at Music City Ketamine when something goes wrong during or after a session — in-the-moment response, follow-up, communication with your other providers, and documentation.
Read more →Seven verifiable green flags when choosing a ketamine clinic — anesthesia on site, real screening, integration partner, transparent pricing, written consent, adverse-event plan, maintenance roadmap.
Read more →Section-by-section walkthrough of the informed consent forms used at Music City Ketamine — what each clause means, why it's there, and your right to withdraw at any time.
Read more →KAP, clinical, or somewhere in between. Here's how therapist presence actually works — and what we offer at MCK.
Read more →What to expect when you bring a partner or family member to your ketamine consultation — what they can do, what we will and won't share, and how driver logistics work for session days.
Read more →Standard SAMHSA-5 workplace drug tests do not screen for ketamine. Extended panels can. Detection windows, metabolites, and what to know if you're tested.
Read more →The honest list of who we turn away from ketamine — and why saying no is part of running a safe clinic.
Read more →What a CRNA actually does during an IV ketamine session — pump titration, continuous vitals, airway, and the honest answer about when she steps out.
Read more →Anxiety during a ketamine session is normal — and manageable. Preparation, grounding, and what the clinical team actually does when fear spikes.
Read more →Fasting before ketamine, medication interactions, and the conversation to have with your CRNA. ASA fasting guidelines and Andrade's interaction review, in plain English.
Read more →Mt. Juliet to our Franklin clinic is about 30-35 minutes via I-40 to I-65. Here's the route, the parking, and what to expect.
Read more →Hendersonville to our Franklin clinic is about 30-35 minutes via I-65. Here's the route, the parking, and why it's worth the drive.
Read more →Rodriguez 2013 was the first RCT showing a glutamate drug works in OCD without an SRI on board. Here's what it found — and what's happened in the harder OCD population since.
Read more →Diazgranados 2010 was the first RCT of ketamine in bipolar depression. Here's what it found, what's followed, and how this differs from unipolar TRD.
Read more →Glue 2017 was the first real ketamine-for-anxiety RCT. Here's what it showed, what's followed, and how to think about the harder anxiety cases that haven't responded to SSRIs.
Read more →Tinnitus has a glutamate story but the human ketamine evidence isn't there. We treat the depression and anxiety around tinnitus — not tinnitus itself.
Read more →Postpartum anxiety is underdiagnosed and understudied. Here's an honest read of where ketamine might fit and where the OB conversation has to come first.
Read more →PMDD is a real biological condition, not severe PMS. The ketamine evidence is small but the mechanism — glutamate, estrogen receptors, anxiety — adds up to a reasonable conversation.
Read more →Phantom limb pain is one of ketamine's better-supported chronic-pain indications. Eichenberger 2008 showed real benefit; here's the evidence and how to think about it.
Read more →Moral injury isn't PTSD. The wound is guilt and shame, not fear. Ketamine doesn't fix that — but it can lift the depression that lands on top.
Read more →Firefighter suicidal-ideation rates are roughly triple the general population. Here's a cohort-specific look at how ketamine fits — confidentiality, scheduling, and all.
Read more →Combat PTSD and MST produce different symptom profiles and require different treatment frames. Here's how a careful clinic adapts a ketamine course for the harder of the two.
Read more →ME/CFS has no large ketamine RCT — but the depression overlap, central-sensitization mechanism, and long-COVID parallels create a real clinical question. Here's an honest look.
Read more →Suicidal ideation in bipolar depression is a medical emergency first. Here's a careful read of the Wilkinson 2018 IPD meta-analysis and where ketamine fits in the longer plan.
Read more →An annual review of what's new in ketamine therapy — 2024-2026 trials, Spravato monotherapy, the FDA's at-home stance, MDMA news, and current guidelines.
Read more →Uncontrolled hyperthyroidism is a real ketamine caution; untreated hypothyroidism is a common, reversible cause of depression. What to know before booking.
Read more →Stopping your SSRI to 'be ready' for ketamine is one of the most common — and most dangerous — myths. Here's the actual interaction picture and the discontinuation risk.
Read more →Krupitsky's studies showed ketamine-assisted psychotherapy increased abstinence in alcohol- and heroin-dependent patients. What the addiction-medicine literature says about ketamine and sobriety.
Read more →Ketamine reliably raises blood pressure during infusion. What the Spravato label and ASRA consensus say, and how we screen and monitor.
Read more →Ketamine stresses the cardiovascular system. How we screen patients with cardiac history, what the ASRA consensus and Spravato label say, and when we say no.
Read more →EMDR plus ketamine pairs trauma reprocessing with the post-infusion neuroplastic window. Here's the rationale, the evidence, and how integration actually gets scheduled.
Read more →Eating-disorder ketamine evidence is small and case-based. The realistic use is treating the depression, anxiety, and OCD that travel with the ED — coordinated with your ED team.
Read more →Ketamine is a bronchodilator — anesthesiologists have used it for severe asthma for decades. What that means for asthmatic patients considering ketamine therapy.
Read more →An honest framework for ketamine non-response — what the evidence actually says about timing, and when to stop and pivot.
Read more →The actual checklist we use before sending you home after a ketamine session — alertness, vitals, gait, ride, and why the clock doesn't matter.
Read more →Your PCP wants to help but may not know recent ketamine evidence. Here's how to bring it up — and what to bring with you.
Read more →Practical pre- and post-infusion food guidance — fasting windows, hydration, and the truth about nausea management.
Read more →An honest minute-by-minute account of what a ketamine infusion actually feels like, from onset to next-day integration.
Read more →Dissociation during ketamine therapy is measurable, time-limited, and clinically tracked. Here is how it works and what it is not.
Read more →Ketamine clinics in Tennessee operate under DEA, state board, and AANA standards. Here's the framework — and what to ask before you book.
Read more →Oral ketamine bioavailability is ~16 percent. IV is 100 percent. Here is what that actually means for dose control and safety.
Read more →An honest comparison of ketamine and psilocybin — legal status, evidence, mechanism, and what is actually available to patients today.
Read more →Where MDMA-assisted therapy stands after the FDA's August 2024 decision, and how ketamine compares for PTSD treatment today.
Read more →Brentwood is about 10 minutes from our Franklin clinic. Here's what the drive, parking, and first session look like.
Read more →How superbills work for ketamine therapy and what to realistically expect from out-of-network reimbursement. No payer-specific promises.
Read more →Music shapes the arc of a ketamine session. Here's what research and our clinical practice say about playlists, headphones, and eye masks.
Read more →How ketamine interacts with lamotrigine, benzodiazepines, stimulants, SSRIs, and MAOIs. Never stop a medication without talking to your prescriber.
Read more →20+ years of evidence, in plain English: what Murrough's RCT, the Spravato approval, and the studies in between actually tell us about ketamine for treatment-resistant depression.
Read more →Perimenopausal women face roughly 2x the major-depression risk. Here's how the MDD ketamine evidence and NAMS guidance fit together for this cohort.
Read more →IASP defines neuropathic pain as nerve-injury pain. Niesters' review shows prolonged ketamine infusions can produce analgesia lasting up to 3 months — here's how that translates to real care.
Read more →Long COVID often includes depression, anxiety, and brain fog. Direct ketamine evidence is limited — here's the honest picture and how the underlying MDD/anxiety data applies.
Read more →Healthcare workers have elevated rates of depression, PTSD, and suicide. There is no HCW-specific ketamine trial — but the underlying MDD and PTSD evidence applies, with confidentiality at the center.
Read more →Prolonged grief disorder is now in the DSM-5-TR. There is no grief-specific ketamine trial — here's the honest framing on when grief crosses into something else.
Read more →Two 2009 RCTs by Sigtermans and Schwartzman established ketamine as a real option for refractory CRPS. Here's what they found and how protocols translate to outpatient care.
Read more →Complex PTSD is recognized in ICD-11 but most ketamine trials studied chronic PTSD, not C-PTSD. Here's what we can — and can't — honestly say about the evidence.
Read more →A 2024 systematic review (Pain and Therapy) and a 2021 intranasal trial suggest ketamine may help cluster headaches. The evidence is emerging — here's the honest picture.
Read more →WHO classifies burnout as an occupational phenomenon, not a diagnosis. Here's how to tell when 'burnout' is actually depression — and when ketamine fits.
Read more →We don't provide elective ketamine in pregnancy. ACOG, FDA, and LactMed all signal caution. Here's the honest picture and why your OB has to lead this decision.
Read more →What ketamine-assisted psychotherapy actually means, the three common models, and what the evidence says about pairing medicine with therapy.
Read more →Ketamine isn't an ADHD treatment. But ADHD comorbidity with depression and anxiety is common — here's the honest line between mechanism interest and clinical evidence.
Read more →How HSA and FSA accounts generally apply to ketamine therapy, the IRS framing, and the Letter of Medical Necessity. Not legal or tax advice.
Read more →How to find a qualified ketamine integration therapist in Tennessee, what credentials matter, and questions to ask before you book.
Read more →Why every reputable clinic requires a ride home, what the FDA says, and how long until you can drive again.
Read more →True flashbacks during medical ketamine are rare. Here's what the evidence shows — and how we keep PTSD treatment contained.
Read more →Tears during a session aren't a problem — they're often the point. Here's why emotional release is part of the work.
Read more →A 2025 study in Neuron found ketamine repairs weakened synaptic connections in the brain’s reward center, restoring motivation and the capacity for pleasure within hours of infusion.
Read more →Emerging research—including a current UCSF clinical trial—suggests IV ketamine may help treatment-resistant eating disorders by increasing cognitive flexibility and disrupting rigid thought patterns about food.
Read more →CRPS scores higher than amputation on the McGill Pain Index. IV ketamine produces greater pain reductions for CRPS than any other chronic pain condition, with zero adverse effects reported in 1,034 patients.
Read more →Standard antidepressants carry heightened risks in older adults—falls, cognitive dulling, dangerous drug interactions. A 2025 review of 757 patients found IV ketamine safely reduces depression with stable or improved cognition.
Read more →Fibromyalgia is driven by NMDA receptor dysfunction and central sensitization. A 2025 study found 41.5% of patients achieved complete response to IV ketamine, with an additional 15% reporting partial improvement.
Read more →IV ketamine achieves 48–61% response rates in treatment-resistant bipolar depression with minimal mania risk—only 4.5% experienced mild hypomania across studies, with zero cases of full mania.
Read more →For patients with chronic or refractory migraines, IV ketamine targets the NMDA receptors driving central sensitization — with 66% of patients reporting 50% or greater improvement in clinical data.
Read more →First responders develop PTSD and depression at 2–3x civilian rates. A 2025 study found ketamine-assisted therapy significantly reduced trauma, anxiety, and depression symptoms in this population.
Read more →A landmark NEJM study found IV ketamine achieved a 55.4% response rate vs 41.2% for ECT — with no memory side effects and no general anesthesia required.
Read more →The FDA has issued warnings about compounded at-home ketamine. Compare safety, bioavailability, monitoring, and what matters most when choosing how you receive treatment.
Read more →A 2025 meta-analysis found comparable efficacy between IV ketamine and TMS — but very different timelines, side effects, and treatment experiences.
Read more →From “party drug” to “one-time fix” — the most common misconceptions about ketamine therapy, addressed with evidence and empathy.
Read more →A March 2026 study in Molecular Psychiatry reveals how ketamine reshapes NMDA receptor activity in mood and reward circuits. Plus the Cleveland Clinic's landmark 1,000-patient chronic pain study.
Read more →Harvard's 2025 study compared IV ketamine and intranasal esketamine head-to-head. Here is what they found, and what it means for your treatment decision.
Read more →A practical, step-by-step guide to preparing for your first session — what to eat, what to wear, what it feels like, and how to make the most of it.
Read more →Practical strategies for the 24–72 hours after your infusion when your brain is most receptive to forming new connections.
Read more →Sleep disturbances and mental health conditions share a bidirectional relationship. Treating one often helps the other.
Read more →Veterans face uniquely high rates of treatment-resistant PTSD, TBI, and chronic pain. Ketamine therapy offers a different approach.
Read more →The infusion opens a door. What you do in the days and weeks after helps determine how long the benefits last.
Read more →Most mental wellness protocols start with six sessions over two to three weeks. But every patient is different.
Read more →Located in the Cool Springs area of Franklin, just off I-65. Easy access from Nashville, Brentwood, Spring Hill, and Murfreesboro.
Read more →Provider credentials, monitoring equipment, and patient-to-staff ratio matter more than most people realize.
Read more →Ketamine has been FDA-approved for anesthesia since 1970. Off-label use for depression and pain is legal and increasingly common.
Read more →With over 50 years of clinical use and a well-understood safety profile, ketamine remains one of the most studied medications in medicine.
Read more →Transparent pricing, financing options, and what your investment actually covers at a CRNA-supervised clinic.
Read more →A Certified Registered Nurse Anesthetist brings doctorate-level training and 8+ years of education to every ketamine session.
Read more →Ketamine targets the glutamate system — a completely different pathway than SSRIs. Here is what that means for your brain.
Read more →Research shows ketamine can reduce suicidal ideation within hours — far faster than traditional antidepressants.
Read more →For the 30–40% of OCD patients who do not respond to SSRIs, ketamine may offer a fundamentally different approach.
Read more →Opioids mask pain signals. Ketamine addresses the nervous system dysfunction that keeps chronic pain circuits firing.
Read more →Ketamine may help the brain process traumatic memories differently by promoting fear extinction and neuroplasticity.
Read more →For patients with treatment-resistant anxiety, ketamine works through a different mechanism than SSRIs — and much faster.
Read more →IV ketamine targets NMDA receptors to address the nervous system dysfunction behind chronic pain conditions.
Read more →Neuroplasticity does not just help with mood — it may also open new pathways for creative thinking and problem-solving.
Read more →Many patients report improved sleep quality after ketamine therapy — likely because the underlying condition is being addressed.
Read more →Starting ketamine therapy before seasonal depression peaks may help prevent the worst of it rather than just treating symptoms.
Read more →Research suggests ketamine may help reset reward circuits and reduce cravings in patients recovering from substance use disorders.
Read more →When every day matters and traditional antidepressants take weeks to work, ketamine offers a faster timeline for new mothers.
Read more →No commitment. A straightforward conversation about whether ketamine therapy makes sense for your situation.
Start with a simple conversation. No pressure — just clarity.No pressure — just clarity.
Not ready to schedule? Text us at (615) 988-4600.